Latest News - Earnings & Financials

Tuesday, May 30, 2017 | Earnings & Financials

TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team of Accomplished Ophthalmology Veterans

TearClear, an eye health technology company focused on developing a safe and reliable means of delivering preservative-free topical ophthalmic drugs, announced the completion of its Series A financing…

Read the full story

Friday, May 26, 2017 | Earnings & Financials, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces Public Offering of Common Stock

Aerie Pharmaceuticals announced that it has commenced a registered underwritten public offering of $50 million of shares of its common stock. Cantor Fitzgerald & Co. is acting as the sole bookr…

Read the full story

Monday, May 22, 2017 | Earnings & Financials, Eyegate Pharmaceuticals

EyeGate Receives Milestone Payment from Valeant for EGP-437 for Postoperative Ocular Inflammation and Pain

EyeGate Pharmaceuticals announced that it has received its first development milestone from a subsidiary of Valeant under the company's license agreement with Valeant, pursuant to which EyeGate …

Read the full story

Monday, May 22, 2017 | Earnings & Financials, NovaBay Pharmaceuticals

NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE

NovaBay Pharmaceuticals announced receipt of a letter from NYSE MKT LLC on May 16, 2017, stating that it is not in compliance with the continued listing standards (requiring stockholders’ equity…

Read the full story

Wednesday, May 17, 2017 | Earnings & Financials, ONL Therapeutics

ONL Therapeutics Closes Series A Financing to Support Development of Novel Retinal Cell Protection Platform for Treatment of Ocular Diseases

ONL Therapeutics announced that it has closed a $4.25 million Series A round of fundraising, which, combined with the recently announced $1 million grant from the National Eye Institute, will primaril…

Read the full story

Thursday, May 11, 2017 | Acquisitions/Mergers, Earnings & Financials

Lensar and PDL Biopharma Complete Strategic Financial Restructuring of Lensar

Lensar and PDL BioPharma announced the completion of Lensar’s financial restructuring with a court-approved exit plan finalized on May 11, 2017. As part of the plan, PDL will convert most of its…

Read the full story

Thursday, May 04, 2017 | Earnings & Financials, Avedro

Avedro Launches Comprehensive Effort to Secure Coverage and Facilitate Reimbursement of FDA-Approved Corneal Cross-Linking Procedure

Avedro announced a comprehensive effort to secure commercial coverage and support reimbursement of Photrexa Viscous (riboflavin 5’-phosphate in 20% dextran ophthalmic solution), Photrexa (ribofl…

Read the full story

Tuesday, May 02, 2017 | Earnings & Financials

LensGen Closes $21 Million Series A Financing to Advance Modular, Fluid-Optic Accommodating IOL

LensGen, a private company developing Juvene, the first modular, fluid-optic accommodating intraocular lens, has closed a $21 million Series A financing. The financing was led by the corporate venture…

Read the full story

Friday, April 28, 2017 | Earnings & Financials

Opthea Completes A$45 Million Capital Raising

Opthea announced the completion of its A$45 million capital raising launched on April 3, 2017. The proceeds from this offering enable the acceleration and diversification of the company's clinical…

Read the full story

Thursday, April 27, 2017 | Earnings & Financials, Avedro

Avedro Announces $42 Million in Funding to Support Commercial Expansion and Pipeline Development

Avedro announced that it secured a combined $42 million in equity and debt financing. The equity financing was led by HealthQuest Capital, with support from existing investors OrbiMed Advisors and Int…

Read the full story

Wednesday, April 26, 2017 | Earnings & Financials, Alcon

Novartis Pushes Pipeline But Keeps An Eye On Alcon

Investors reacted well to a decent first quarter from Novartis that suggested that the long-awaited turnaround in its Alcon eyecare division has begun. While there is still investment needed, especial…

Read the full story

Thursday, March 30, 2017 | Earnings & Financials, Valeant

Ackman: Investment in Valeant a 'Huge Mistake'

In his annual letter to investors of his hedge fund, Bill Ackman “deeply and profoundly” apologized for his investment in Valeant, a move that ultimately cost Pershing Square Capital Manag…

Read the full story

Wednesday, March 29, 2017 | Earnings & Financials, Allergan

Allergan's CEO Pay Plummets by 80%

After a 2016 that hit some bumps financially -- and one that didn’t feature the Pfizer-Allergan merger the companies had planned on -- Allergan CEO Brent Saunders’ pay is down. Way, way do…

Read the full story

Tuesday, March 21, 2017 | Earnings & Financials, ONL Therapeutics

ONL Therapeutics Receives Nearly $1 Million Grant from National Eye Institute for Continued Advancement of ONL1204 Program

ONL Therapeutics announced that the company has been awarded a Commercialization Readiness Pilot (CRP) grant of approximately $1 million from the National Eye Institute (NEI) to continue advancement o…

Read the full story

Friday, March 17, 2017 | Earnings & Financials, Retina, Aerpio Therapeutics

Aerpio Pharmaceuticals Raises $40 Million

Aerpio Pharmaceuticals, a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases, announced the successful completion of its reverse merger transaction with Aerpi…

Read the full story
Load More